Search the Archive

A Closer Look (Cancer Costs) #833421

ABC Evening News for Tuesday, Jul 11, 2006
View other clips in this broadcast →

Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws.

(Studio: Kate Snow) The skyrocketing cost of cancer drugs introduced; statistics cited.

(New York: John McKenzie) The costly targeted therapy drugs used in the war on cancer featured; examples cited of the annual cost of Tarceva, Herceptin, Erbitux. [Memorial Sloan-Kettering Cancer Center Dr. Deborah SCHRAG†- cites the co-payment costs.] [Liver cancer patient Jim BEUTTELL†- reacts to his drug cost.] [Vanderbilt University Medical Center Dr. David JOHNSON†- says some patients opt out of therapy.] [Genentech Dr. Susan HELLMANN†, SCHRAG - offer differing opinions on the cost to drug companies.]

Reporter(s):
Snow, Kate;
McKenzie, John
Duration:
00:02:30

Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.

Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:

  • You may request a loan of this video by registering on our website and placing an order.
  • You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
  • If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.

If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.